Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 04-2007 | 01-2007 | 10-2006 | 07-2006 | 04-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 766 | 828 | 1,282 | 611 | 732 |
| Marketable Securities | 425 | 425 | 38 | 398 | 398 |
| Receivables | 60 | 69 | 10 | 38 | 68 |
| Inventories | 231 | 243 | 261 | 281 | 308 |
| TOTAL | $1,524 | $1,597 | $1,623 | $1,364 | $1,566 |
| Non-Current Assets | |||||
| PPE Net | 25 | 22 | 23 | 26 | 28 |
| Investments And Advances | 417 | 417 | 207 | 207 | 97 |
| Other Non-Current Assets | 11 | 11 | 11 | 5 | 5 |
| TOTAL | $453 | $450 | $241 | $238 | $130 |
| Total Assets | $1,977 | $2,048 | $1,864 | $1,601 | $1,696 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 199 | 318 | 533 | 253 | 313 |
| Accrued Expenses | 129 | 49 | 49 | 39 | 59 |
| TOTAL | $328 | $367 | $582 | $292 | $372 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $328 | $367 | $582 | $292 | $372 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,149 | 4,084 | 4,056 | 3,880 | 3,831 |
| Common Shares | 1,035 | 1,019 | 993 | 968 | 952 |
| Retained earnings | -83,714 | -82,282 | -80,509 | -78,707 | -76,560 |
| TOTAL | $1,649 | $1,680 | $1,282 | $1,309 | $1,325 |
| Total Liabilities And Equity | $1,977 | $2,048 | $1,864 | $1,601 | $1,696 |